FluidForm Bio logo — company profile

FluidForm Bio

Founded 2018 United States Waltham, United States 16 employees Series Unknown Total: $499.64K Biopharma, Biotechnology +3

General Information

Company Name FluidForm Bio
Founded Year 2018
Location United States Waltham, United States +1
Employees 16
Industries Biopharma, Biotechnology, Health Care +2
Funding Stage Series Unknown
Social

Get notified when FluidForm Bio moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About FluidForm Bio

FluidForm Bio is a groundbreaking startup in the biopharma, biotechnology, and health care industries. Established in 2018 and headquartered in the United States, the company is revolutionizing the medical field with its visionary approach. Through their pioneering FRESH™ technology, which constructs living human tissue using cells and proteins exclusively, FluidForm Bio aims to address a wide array of diseases. The company has garnered significant attention and support, recently securing a Venture Round investment on 11 January 2022, with backing from Hackensack Meridian Health. Through strategic partnerships with leading life science companies, FluidForm Bio's technology has been proven to generate top-tier tissue for various medical applications. By leveraging groundbreaking advancements in 3D printing, computational and synthetic biology, AI, and advanced materials science, the company is poised to provide patients with unparalleled treatment options. FluidForm Bio's innovative approach offers promise for the future of healthcare as it strives to deliver high-quality living tissue for improved therapeutics.

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 1 •••• •••• 11 Jan 2022
Series A •••••• 1 •••• •••• 05 Nov 2021
Grant •••••• 1
Investor
21 Apr 2021
Convertible Note •••••• 1
Investor
05 Nov 2020
Seed Round •••••• 1
Investor
11 Sep 2019

FluidForm Bio Alternatives & Competitors

FluidForm Bio vs
BIOLIFE4D
BIOLIFE4D United States

Build a Heart. Save a Life.

7 employees
Biotechnology
FluidForm Bio vs

Our mission is to be an excellent regulator for the use of human tissue with consent and safety.

78 employees
Biotechnology, Health Care
FluidForm Bio vs

We develop advanced 3D tools for the future of personalized medicine.

13 employees
Biotechnology, Pharmaceutical

FAQ About FluidForm Bio

FluidForm Bio™ is creating living human tissue for better treatment of disease. Our patented FRESH™ technology is a revolutionary platform designed to build tissue using cells, proteins, and nothing else. Through partnerships with top life science companies, our technology has been validated to prod...
FluidForm Bio was founded in 2018.
FluidForm Bio is headquartered in Waltham, United States.
FluidForm Bio operates in the following industries: Biopharma, Biotechnology, Health Care, VR/AR, 3D Printing.
FluidForm Bio has approximately 16 employees.
FluidForm Bio has completed 5 funding rounds, raising a total of $499.64K. The latest funding stage is Series Unknown.
Top alternatives and competitors to FluidForm Bio include BIOLIFE4D, Human Tissue Authority, Vital3D Technologies, TheraDep, Springbok Analytics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
FluidForm Bio and BIOLIFE4D are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors FluidForm Bio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy